Misonix to Report Fiscal 2019 Fourth Quarter Financial Results and Host Conference Call and Webcast on August 14
August 07 2019 - 2:00PM
Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a
provider of minimally invasive therapeutic ultrasonic medical
devices that enhance clinical outcomes, announced today that it
will report its fiscal 2019 fourth quarter financial results after
the market closes on Wednesday, August 14, 2019. The Company will
host a conference call and webcast at 4:30 p.m. ET that day to
review the results. Both the call and webcast are open to the
general public.
To access the conference call, interested
parties may dial 888/220-8451 (domestic) or 323/794-2588
(international) conference ID 1769560. Participants may also listen
to a live webcast of the call through the “Events and
Presentations” section under “Investor Relations” on Misonix’s
website at www.misonix.com. A webcast replay will be available for
30 days following the live event at www.misonix.com.
Please call five minutes in advance to ensure
that you are connected. Questions and answers will be taken only
from participants on the conference call. For the webcast, please
allow 15 minutes to register, download and install any necessary
software.
About Misonix, Inc.
Misonix, Inc. (NASDAQ: MSON) designs,
manufactures and markets ultrasonic medical devices for the precise
removal of hard and soft tissue, including bone removal, wound
debridement and ultrasonic aspiration. Misonix is focused on
leveraging its proprietary ultrasonic technology to become the
standard of care in operating rooms and clinics around the world.
Misonix's proprietary ultrasonic medical devices are used in a
growing number of medical procedures, including spine surgery,
neurosurgery, orthopedic surgery, cosmetic surgery, laparoscopic
surgery, and other surgical and medical applications. At Misonix,
Better Matters to us. That is why throughout the Company’s history,
Misonix has maintained its commitment to medical technology
innovation and the development of ultrasonic surgical products that
radically improve patient outcomes. Additional information is
available on the Company's web site at www.misonix.com.
Contact: Joe Dwyer
Joseph Jaffoni, Norberto Aja, Jennifer
NeumanChief Financial Officer
JCIRMisonix, Inc.
212-835-8500 or
mson@jcir.com631-927-9113
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Mar 2024 to Apr 2024
Misonix (NASDAQ:MSON)
Historical Stock Chart
From Apr 2023 to Apr 2024